With these words, the president of the\u00a0National Federation of Orders of Surgeons and Dentists\u00a0<\/strong>(Phnomceo) Philip\u00a0Rings<\/strong>, together with the entire Executive, comments on press reports according to which the Minister, together with the Regions, intends to adopt, as a criterion for reimbursement of medicines, that of "therapeutic equivalence<\/em>\u201d, according to which to be reimbursed would be \u201cAs for the waiting lists, they will not be reduced by acting on intramoenia but only by increasing the number of specialists<\/em>- continues\u00a0Rings<\/strong>, responding to the statements made yesterday by the Minister on the occasion of the meeting with the Health Commission of the Conference of the Regions -.\u00a0This proposal would increase inequalities between Regions, penalizing those that have staff shortages".<\/em><\/p>\n \u201cWhat has been reported seems to go in a clearly opposite direction to the programmatic declarations for greater universality and fairness of the National Health Service<\/em>\u00a0\u2013 concludes the president\u00a0Phnomceo<\/strong>\u00a0-.\u00a0To overturn the responsibility of waiting lists on doctors, rather than on those who manage health care, seems to us completely out of place, just as it is strongly penalizing for citizens to ration spending according to economic logic rather than objectives of appropriateness and health".<\/em><\/p>\n Related news: Cricket. Healthcare revolution. Drugs: with the same therapeutic efficacy, the State will reimburse the least expensive one<\/a><\/p>\n Therapeutic equivalence between different active ingredients. Even Radiologists say NO<\/a><\/p>\n SNAMI. NO to therapeutic equivalence of drugs. Not everything is allowed in the name of savings<\/a><\/p>\n Fimmg. Therapeutic equivalence, Silvestro Scotti: "For drugs "one is worth one", be careful not to question the freedom of doctors to act in science and conscience"<\/a><\/p>\n AIFA. Determination 818\/2018 - therapeutic equivalence<\/a><\/p>\n![\"\"](\"https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2018\/06\/Giulia-Grillo-1-1024x576.jpg\")
<\/a>\u201cWe learn from an article published today in the newspaper\u00a0The print<\/strong>\u00a0that the Minister of Health, the Hon. Giulia\u00a0Cricket<\/strong>, would be preparing, together with the Regions, a revolution in the pharmaceutical handbook, where medicines would no longer be classified and reimbursed by active ingredient but according to 'homogeneous therapeutic classes'. If the news corresponded to the truth, we would be seriously concerned: initiatives of this kind can in fact have a serious impact on health inequalities, in this case discriminating against those on a lower income, who, not being able to pay for drugs or overprices, would have to be satisfied with the drug which costs less, the only one provided entirely by the National Health Service\u201d.<\/em><\/p>\n![\"\"](\"https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2018\/01\/Filippo-Anelli-Fnomceo1.jpg\")
<\/a>the lowest-cost medicine among all those that have the same mechanism of action, even if different in terms of active ingredient.<\/p>\n